Brief: Hugel product "Botulax" gets selling license from Russia
Dec 6 (Reuters) - Hugel Inc 145020.KQ :
* Says its main product "Botulax" got selling license from
Ministry of Health of Russian Federation on Nov. 23
* Says it expects a sales increase of "Botulax" in Russia
Source text in Korean: https://goo.gl/NT1Wep
Further company coverage: 145020.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Hugel
See all newsBrief: Hugel To Cancel 54 Billion Won Worth Of Own Shares
Brief: Hugel Q3 Operating Profit 18 Billion Won, Down 62% From Year Earlier
Brief: Hugel Reports Q2 2026 Net Sales Up 25.1% TO KRW 137.90 Billion
Brief: Hugel Q4 Operating Profit 58.6 Billion Won, Up 26% From Year Earlier
Brief: Hugel Q3 Operating Profit 47.4 Billion Won, Down 11% From Year Earlier